Automated Manufacturing of Potent CD20-Directed Chimeric Ant…

Well Cited


116
Citations
30
Refs
2017
Year
Search Works
Work Details
  • DOI 10.1089/hum.2017.111
  • PMID https://pubmed.ncbi.nlm.nih.gov/28847167
  • OpenAlex ID W2761560083
  • Type Article
  • Language EN
  • Published 29 Aug 2017
  • Volume 28 (10)
  • Pages 914–925
  • Source Human Gene Therapy
  • Publisher Mary Ann Liebert, Inc.
  • FWCI 5.43
  • Countries 1
  • Institutions 2
  • Added 20 Oct 2017
  • Updated 31 Oct 2026
MENU
0

Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use

Article 2017 EN Hybrid

The clinical success of gene-engineered T cells expressing a chimeric antigen receptor (CAR), as manifested in several clinical trials for the treatment of B cell malignancies, warrants the development of a simple and robust manufacturing procedure capable of reducing to a minimum the challenges associated with its complexity. Conventional protocols comprise many open handling steps, are labor int…

116

Citations

30

References

15

Authors

5.43

FWCI

Citations by Year
Last 9 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
15 authors
#AuthorInstitutionsORCID
1 Dominik Lock Miltenyi Biotec (Germany) (DE)
2 Nadine Mockel-Tenbrinck Miltenyi Biotec (Germany) (DE) —
3 Katharina Drechsel Miltenyi Biotec (Germany) (DE) —
4 Carola Barth Miltenyi Biotec (Germany) (DE) —
5 Daniela Mauer Miltenyi Biotec (Germany) (DE)
6 Thomas Schaser Miltenyi Biotec (Germany) (DE)
7 Carolin Kolbe Miltenyi Biotec (Germany) (DE) —
8 Wa’el Al Rawashdeh Miltenyi Biotec (Germany) (DE) —
9 Janina Brauner Miltenyi Biotec (Germany) (DE) —
10 Olaf Hardt Miltenyi Biotec (Germany) (DE)
11 Natali Pflug University Hospital Cologne (DE)
12 Udo Holtick University Hospital Cologne (DE)
13 Peter Borchmann University Hospital Cologne (DE)
14 Mario Assenmacher Miltenyi Biotec (Germany) (DE) —
15 Andrew Kaiser Miltenyi Biotec (Germany) (DE) —

Data: OpenAlex